World Clinical Drug
|
2024, 45(12): 1300-1302
• Article •
Treatment of refractory rheumatoid arthritis with telitacicept: a case report and literature review
Full
Lei QIN1, Jie XU2, *
Affiliations
- 1.Department of Rheumatology and Immunology, Shandong Second People's Hospital, Jinan 250022, Shandong Province, China
- 2.Health Management Center, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
Published: 2024-12-10
doi: 10.13683/j.wph.2024.12.014
Outline
telitacicept
/
rheumatoid arthritis
/
biological agent
秦蕾, 徐婕.
泰它西普治疗难治性类风湿关节炎1例及文献回顾.
世界临床药物,
2024
, 45
(12)
: 1300
-1302
.
DOI: 10.13683/j.wph.2024.12.014
Lei QIN, Jie XU.
Treatment of refractory rheumatoid arthritis with telitacicept: a case report and literature review[J].
World Clinical Drug,
2024
, 45
(12)
: 1300
-1302
.
DOI: 10.13683/j.wph.2024.12.014
Year 2024 volume 45 Issue 12
14
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.12.014
- Receive Date:2024-10-28
- Online Date:2026-11-17
- Published:2024-12-10